Checkmate Pharmaceuticals...

NASDAQ: CMPI · Real-Time Price · USD
10.50
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Checkmate Pharmaceuticals Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
n/a
Cost of Revenue
n/a
Gross Profit
n/a
Operating Income
-61.41M
Interest Income
100K
Pretax Income
-61.41M
Net Income
-61.41M
Selling & General & Admin
15.65M
Research & Development
45.82M
Other Expenses
n/a
Operating Expenses
61.47M
Interest Expense
n/a
Selling & Marketing Expenses
n/a
Cost & Expenses
61.47M
Income Tax Expense
n/a
Shares Outstanding (Basic)
21.63M
Shares Outstanding (Diluted)
21.63M
EPS (Basic)
-2.84
EPS (Diluted)
-2.84
EBITDA
-61.34M
EBIT
-61.41M
Depreciation & Amortization
66K